SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-05-063339
Filing Date
2005-12-14
Accepted
2005-12-14 19:12:04
Documents
2
Period of Report
2005-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2125
2 POA DOCUMENT poa.txt EX-24.3_112854 2855
  Complete submission text file 0001209191-05-063339.txt   6781
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 550 HAMILTON AVENUE, SUITE 100 PALO ALTO CA 94301
Business Address (650) 325-5156
Topper James N (Reporting) CIK: 0001341382 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24274 | Film No.: 051265025